$ERBB -Recent PR!!! American Green (ERBB:OTC) is On-Target

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
149
$ERBB -Recent PR!!! American Green (ERBB:OTC) is On-Target to Have Its Best Year Yet

GlobeNewswire•June 11, 2020


Cannabis Grow Management, Online CBD Sales, and Smart Vending Division all set to break revenue records in 2020 compared to 2019
PHOENIX, AZ, June 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Green(ERBB:OTC) announced today that the strategic shifts that began in 2019 are now paying dividends in every division. According to David Gwyther, president of American Green, “During 2019 and early 2020, the company had to make changes in every division to accommodate the changing marketplace. I’m pleased to report that those changes resulted in each division’s revenue improvements compared to the same periods over the previous year.”
VP of CBD Worldwide Sales, Kevin Davis, said, “The key to the success of the American Green Online CBD Store is a combination of Top-Shelf Customer Service, The Integration of Technology, Competitive Pricing, Easy Payment Options, and Product Selection.Since our online CBD Store first opened 3 years ago, our growth has been primarily driven by our extreme sensitivity to customer feedback - by listening very, very carefully. Whether that means incorporating a capability to quickly respond to customer questions via email or phone, and making damn sure our customers know that they’re getting the best CBD available and are 100% satisfied, even if that means staying on the phone with them until they get all the information they need.
“Every customer is unique to us and when our store employees show them the courtesy of our unrushed time - whether by email or phone, it is the only way we know of guaranteeing that our loyal base returns to us. Other companies talk about achieving goals like these, but we at the American Green CBD Store live this ‘customer-driven lifestyle’ every day,” concludes Kevin.
According to Bryan Croteau, American Green’s VP of Grow Operations, “As the world comes out of quarantine and things get back to the ‘new normal,’ American Green’s ‘Sweet Virginia’ is turning out some of the highest grade cannabis found in Arizona and is hard at work upgrading its production facility while producing American Green’s newest cannabis product line. Our Sweet Virginia facility is proud to announce that the first wave of American Green Full Spectrum Solventless Concentrate products have hit the retail shelves at the Kind Meds licensed dispensary located at 2152 South Vineyard, Suite 120, Bldg 7, Mesa AZ 85210.”
American Green’s Sweet Virginia grow operation is most proud of its Ice-water-extractedBubble Hash which is also known as “Full Melt,” because it leaves no residue when compared to standard hash which has been made the same way for hundreds of years. According to Mr. Croteau, “Our special process manually removes the THC trichomes using nothing but ice and water and produces one of the safest and most natural concentrates available anywhere. If you are a current medical patient in the State of Arizona, we highly recommend a trip to Kind Meds for an opportunity to taste our best grown flowers in the form of concentrate! I would call first before making the trip to ensure that the American Green Bubble Hash has not been sold out, as we anticipate high demand for this premium product.”
The Sweet Virginia Grow has also recently added 10% of canopy space as an additional flower room thus enabling the operation to increase its revenues by about 10% per annum. This new space will allow for production of an extra 240 plants every 8 weeks. We are also constantly streamlining tasks to be as efficient as possible, which has allowed us to cut our current payroll costs by about 12% when compared to last quarter.
The American Green Machine (AGM) Division has been working to add new features to its Smart Vending Kiosk such as lower risk touchless shopping which will allow vending customers to utilize a QR Code and be able to use their own cell phone to interact with our AGM Kiosk. Employing “COVID-19 Sensitivity,” customers will no longer need to touch the machine to view the AGM’s products with the goal of allowing customers to complete their entire transaction on their smartphone. This new feature has been designed to be “backwards compatible” thus enabling the feature to be available for existing machines already in service. and is now ready to rollout. According to AGM Division VP, Lindel Creed, “We are very excited with the progress of the AGM kiosk as sales increase this year and more customers become convinced that the AGM is the best verified vending system on the market.”

If you are an experienced vending route operator serving a major market and wish to add a complete line of fully legal CBD products to your existing route, you should contact Mr. Lindel Creed at American Green’s AGM Vending Division located in Gastonia, North Carolina. You can email Lindel at lindel@americangreen.comor call him on his direct line at 704-718-3158.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading